An Observational Study Evaluating Therapy Optimisation Using High-frequency and High-dosage Administration of Interferon-beta (Rebif®) in Multiple Sclerosis (MS) Patients

Clinical trial NCT01142453 · COMPLETED

Trial details

NCT number: NCT01142453
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing-Remitting Multiple Sclerosis

Start date: 2005-05-01
Primary completion: 2008-06-01
Enrollment: 231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.